Renal denervation suppresses atrial fibrillation in a model of renal impairment

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Liang, Zhuo ^a   Shi, Xiang Min ^a   Liu, Li Feng ^a   Chen, Xin Pei ^b   Shan, Zhao Liang ^a   Lin, Kun ^a   Li, Jian ^a   Chen, Fu Kun ^a   Li, Yan Guang ^a   Guo, Hong Yang ^a   Wang, Yu Tang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; C REACTIVE PROTEIN; GELATIN SPONGE; INTERLEUKIN 6; NORADRENALIN; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEAGLE; BLOOD PRESSURE; CARDITIS; CONTROLLED STUDY; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE FIBROSIS; HEART MUSCLE REFRACTORY PERIOD; HEART RATE; KIDNEY ARTERY EMBOLIZATION; KIDNEY DENERVATION; KIDNEY ISCHEMIA; MILD RENAL IMPAIRMENT; NONHUMAN; P WAVE; RADIOFREQUENCY ABLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPATHETIC NERVE; WENCKEBACH PERIOD; ADRENERGIC SYSTEM; ANIMAL; ATRIAL FIBRILLATION; AUTONOMIC DENERVATION; BIOLOGICAL MODEL; BLOOD; CATHETER ABLATION; CHEMISTRY; COMPLICATION; DISEASE MODEL; DOG; FIBROSIS; HEART ATRIUM; HEMODYNAMICS; INNERVATION; ISCHEMIA; KIDNEY; KIDNEY ARTERY; KIDNEY ARTERY STENOSIS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; VASCULARIZATION;

ANIMALIA;

ALDOSTERONE; ANGIOTENSIN II; ANIMALS; ATRIAL FIBRILLATION; AUTONOMIC DENERVATION; C-REACTIVE PROTEIN; CATHETER ABLATION; DISEASE MODELS, ANIMAL; DOGS; FIBROSIS; HEART ATRIA; HEMODYNAMICS; INTERLEUKIN-6; ISCHEMIA; KIDNEY; MODELS, CARDIOVASCULAR; NOREPINEPHRINE; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; RENIN; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM;

EID: 84928807020     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124123     Document Type: Article

References (25)

1. Chen LY, Shen WK. Epidemiology of atrial fibrillation: a current perspective. Heart Rhythm. 2007; 4: S1-6. PMID: 17539194
2. Zimmerman D, Sood MM, Rigatto C, Holden RM, Hiremath S, Clase CM. Systematic review and metaanalysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. Nephrol Dial Transplant. 2012; 27: 3816-3822. doi: 10.1093/ndt/gfs416 PMID: 23114904
3. Soliman EZ, Prineas RJ, Go AS, Xie D, Lash JP, Rahman M, et al. Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). Am Heart J. 2010; 159: 1102-1107. doi: 10.1016/j.ahj.2010.03.027 PMID: 20569726
4. Schlaich MP, Socratous F, Hennebry S, Eikelis N, Lambert EA, Straznicky N, et al. Sympathetic activation in chronic renal failure. J Am Soc Nephrol. 2009; 20: 933-939. doi: 10.1681/ASN.2008040402 PMID: 18799718
5. Park HW, Shen MJ, Lin SF, Fishbein MC, Chen LS, Chen PS. Neural mechanisms of atrial fibrillation. Curr Opin Cardiol. 2012; 27: 24-28. doi: 10.1097/HCO.0b013e32834dc4e8 PMID: 22139702
6. Hou Y, Hu J, Po SS, Wang H, Zhang L, Zhang F, et al. Catheter-based renal sympathetic denervation significantly inhibits atrial fibrillation induced by electrical stimulation of the left stellate ganglion and rapid atrial pacing. PLoS One. 2013; 8: e78218. doi: 10.1371/journal.pone.0078218 PMID: 24223140
7. Siragy HM, Carey RM. Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease. Am J Nephrol. 2010; 31: 541-550. doi: 10.1159/000313363 PMID: 20484892
8. Mayyas F, Alzoubi KH, Van Wagoner DR. Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling. Int J Cardiol. 2013; 168: 5135-5142. doi: 10.1016/j.ijcard.2013.08.022 PMID: 23993726
9. Savelieva I, Kakouros N, Kourliouros A, Camm AJ. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention. Europace. 2011; 13: 610-625. doi: 10.1093/europace/eur023 PMID: 21515595
10. Liang Z, Liu L, Chen X, Shi X, Guo H, Lin K, et al. Establishment of a Model of Renal Impairment with Mild Renal Insufficiency Associated with Atrial Fibrillation in Canines. PLoS ONE. 2014; 9: e105974. doi: 10.1371/journal.pone.0105974 PMID: 25157494
11. Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K, et al. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension. 2012; 60: 172-178. doi: 10.1161/HYPERTENSIONAHA.112.191965 PMID: 22585944
12. Zhao Q, Yu S, Huang H, Tang Y, Xiao J, Dai Z, et al. Effects of renal sympathetic denervation on the development of atrial fibrillation substrates in dogs with pacing-induced heart failure. Int J Cardiol. 2013; 168: 1672-1673. doi: 10.1016/j.ijcard.2013.03.091 PMID: 23597574
13. Linz D, Hohl M, Nickel A, Mahfoud F, Wagner M, Ewen S, et al. Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea. Hypertension. 2013; 62: 767-774. doi: 10.1161/HYPERTENSIONAHA.113.01728 PMID: 23959548
14. Toshifumi W, Mika M. Effects of Benazepril Hydrochloride in Cats with Experimentally Induced or Spontaneously Occurring Chronic Renal Failure. J. Vet. Med. Sci. 2007; 69: 1015-1023. PMID: 17984588
15. Zhao Q, Yu S, Zou M, Dai Z, Wang X, Xiao J, et al. Effect of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing. J Interv Card Electrophysiol. 2012; 35: 119-125. doi: 10.1007/s10840-012-9717-y PMID: 22869391
16. Fukunaga N, Takahashi N, Hagiwara S, Kume O, Fukui A, Teshima Y, et al. Establishment of a model of atrial fibrillation associated with chronic kidney disease in rats and the role of oxidative stress. Heart Rhythm. 2012; 9: 2023-2031. doi: 10.1016/j.hrthm.2012.08.019 PMID: 22906534
17. Alonso A, Lopez FL, Matsushita K, Loehr LR, Agarwal SK, Chen LY, et al. Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2011; 123: 2946-2953. doi: 10.1161/CIRCULATIONAHA.111.020982 PMID: 21646496
18. Ewen S, Ukena C, Linz D, Schmieder RE, Bohm M, Mahfoud F. The sympathetic nervous system in chronic kidney disease. Curr Hypertens Rep. 2013; 15: 370-376. doi: 10.1007/s11906-013-0365-0 PMID: 23737218
19. Ye S, Zhong H, Yanamadala V, Campese VM. Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am J Hypertens. 2002; 15: 717-724. PMID: 12160195
20. Wienemann H1, Meincke F, Kaiser L, Heeger CH, Bergmann MW. Treating resistant hypertension with new devices. Minerva Cardioangiologica. 2014; 62: 235-41. PMID: 24831759
21. Ogawa M, Tan AY, Song J, Kobayashi K, Fishbein MC, Lin SF, et al. Cryoablation of stellate ganglia and atrial arrhythmia in ambulatory dogs with pacing-induced heart failure. Heart Rhythm. 2009; 6: 1772-1779. doi: 10.1016/j.hrthm.2009.08.011 PMID: 19959128
22. Redpath CJ, Rankin AC, Kane KA, Workman AJ. Anti-adrenergic effects of endothelin on human atrial action potentials are potentially anti-arrhythmic. J Mol Cell Cardiol. 2006; 40: 717-724. PMID: 16603181
23. Linz D, Mahfoud F, Schotten U, Ukena C, Hohl M, Neuberger HR, et al. Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation. Hypertension. 2012; 61: 225-231. doi: 10.1161/HYPERTENSIONAHA.111.00182 PMID: 23150501
24. Bianchi S, Rossi P, Della Scala A, Kornet L, Pulvirenti R, Monari G, et al. Atrioventricular (AV) node vagal stimulation by transvenous permanent lead implantation to modulate AV node function: safety and feasibility in humans. Heart Rhythm. 2009; 6: 1282-1286. doi: 10.1016/j.hrthm.2009.05.011 PMID: 19716083
25. Thomas H, Jeffrey E. Atrial Fibrosis and the Mechanisms of Atrial Fibrillation. Heart Rhythm. 2007; 4: S24-S27. PMID: 17336879